Prosecution Insights
Last updated: April 19, 2026

Examiner: YANG, TIAN

Tech Center 1600 • Art Units: 1674

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
6
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
13.7%
§102 Novelty
37.3%
§103 Obviousness
23.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18037516 MATERIALS AND METHODS FOR SENSITIZING TUMORS TO IMMUNE RESPONSE Non-Final OA University of Florida Research Foundation, Inc.
18393269 IMMUNOASSAYS AND ENGINEERED PROTEINS FOR MONITORING ANTIBODY TREATMENTS TO THE IMMUNE CHECKPOINT INHIBITORS PD1 AND PD-L1 Non-Final OA GRIFOLS DIAGNOSTIC SOLUTIONS INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month